APA

Califano R., Lal R., Lewanski C., Nicolson M. C., Ottensmeier C. H., Popat S., Hodgson M. & Postmus P. E. (20190129). Patient selection for anti-PD-1/PD-L1 therapy in advanced non-small-cell lung cancer: implications for clinical practice. : Future oncology (London, England).

Chicago

Califano Raffaele, Lal Rohit, Lewanski Conrad, Nicolson Marianne C, Ottensmeier Christian H, Popat Sanjay, Hodgson Matthew and Postmus Pieter E. 20190129. Patient selection for anti-PD-1/PD-L1 therapy in advanced non-small-cell lung cancer: implications for clinical practice. : Future oncology (London, England).

Harvard

Califano R., Lal R., Lewanski C., Nicolson M. C., Ottensmeier C. H., Popat S., Hodgson M. and Postmus P. E. (20190129). Patient selection for anti-PD-1/PD-L1 therapy in advanced non-small-cell lung cancer: implications for clinical practice. : Future oncology (London, England).

MLA

Califano Raffaele, Lal Rohit, Lewanski Conrad, Nicolson Marianne C, Ottensmeier Christian H, Popat Sanjay, Hodgson Matthew and Postmus Pieter E. Patient selection for anti-PD-1/PD-L1 therapy in advanced non-small-cell lung cancer: implications for clinical practice. : Future oncology (London, England). 20190129.